ABILIFY Drug Savings
How to Order
Place a mail order
Save when you get your prescription
mailed to you.
Purchase at pharmacy
Use our discount card to save
up to 65% on your prescription
at participating pharmacies.
Sign up for a FREE Basic Membership now or Login if you're already a member.
INDICATIONS AND USAGE
ABILIFY is an atypical antipsychotic indicated
as oral formulations for:
- Treatment of Schizophrenia in adults and adolescents aged 13 to 17 years
- Treatment of manic or mixed episodes associated with Bipolar I Disorder as monotherapy or adjunctive to lithium or valproate in adults and pediatric patients aged 10 to 17 years
- Adjunctive treatment of Major Depressive Disorder in adults
as an injection for:
- Treatment of adults with agitation associated with Schizophrenia or Bipolar I Disorder, manic or mixed episodes
Schizophrenia
ABILIFY is indicated for acute and maintenance treatment of Schizophrenia in adults and in adolescents 13 to 17 years of age.
Bipolar Disorder
Monotherapy
ABILIFY is indicated for acute and maintenance treatment of manic and mixed episodes associated with Bipolar I Disorder with or without psychotic features in adults and in pediatric patients 10 to 17 years of age.
Adjunctive Therapy
ABILIFY is indicated as an adjunctive therapy to either lithium or valproate for the acute treatment of manic and mixed episodes associated with Bipolar I Disorder with or without psychotic features in adults and in pediatric patients 10 to 17 years of age.
Adjunctive Treatment of Major Depressive Disorder
ABILIFY is indicated for use as an adjunctive therapy to antidepressants for the acute treatment of Major Depressive Disorder in adults.
Agitation Associated with Schizophrenia or Bipolar Mania
ABILIFY Injection is indicated for the acute treatment of agitation associated with Schizophrenia or Bipolar Disorder, manic or mixed in adults. "Psychomotor agitation" is defined in DSM-IV as "excessive motor activity associated with a feeling of inner tension". Patients experiencing agitation often manifest behaviors that interfere with their diagnosis and care (eg, threatening behaviors, escalating or urgently distressing behavior, or self-exhausting behavior), leading clinicians to the use of intramuscular antipsychotic medications to achieve immediate control of the agitation.